Logo image of CBA.CA

CHAMPION BEAR RESOURCES LTD (CBA.CA) Stock Fundamental Analysis

TSX-V:CBA - TSX Venture Exchange - CA15849E1025 - Common Stock - Currency: CAD

0.025  +0.01 (+25%)

Fundamental Rating

0

Taking everything into account, CBA scores 0 out of 10 in our fundamental rating. CBA was compared to 818 industry peers in the Metals & Mining industry. CBA may be in some trouble as it scores bad on both profitability and health. CBA has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

CBA had negative earnings in the past year.
In the past year CBA has reported a negative cash flow from operations.
CBA had negative earnings in each of the past 5 years.
In the past 5 years CBA reported 4 times negative operating cash flow.
CBA.CA Yearly Net Income VS EBIT VS OCF VS FCFCBA.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -1M -2M -3M

1.2 Ratios

Looking at the Return On Assets, with a value of -6.67%, CBA is in the better half of the industry, outperforming 67.12% of the companies in the same industry.
CBA has a Return On Equity (-22.38%) which is in line with its industry peers.
Industry RankSector Rank
ROA -6.67%
ROE -22.38%
ROIC N/A
ROA(3y)-6.1%
ROA(5y)-16.79%
ROE(3y)-17.09%
ROE(5y)-46.66%
ROIC(3y)N/A
ROIC(5y)N/A
CBA.CA Yearly ROA, ROE, ROICCBA.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 -50 -100 -150

1.3 Margins

CBA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CBA.CA Yearly Profit, Operating, Gross MarginsCBA.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023

0

2. Health

2.1 Basic Checks

Compared to 1 year ago, CBA has more shares outstanding
Compared to 5 years ago, CBA has more shares outstanding
Compared to 1 year ago, CBA has a worse debt to assets ratio.
CBA.CA Yearly Shares OutstandingCBA.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
CBA.CA Yearly Total Debt VS Total AssetsCBA.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M

2.2 Solvency

CBA has an Altman-Z score of -7.83. This is a bad value and indicates that CBA is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -7.83, CBA is doing worse than 68.99% of the companies in the same industry.
CBA has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of CBA (0.21) is worse than 66.25% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Altman-Z -7.83
ROIC/WACCN/A
WACCN/A
CBA.CA Yearly LT Debt VS Equity VS FCFCBA.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1M 2M 3M 4M

2.3 Liquidity

CBA has a Current Ratio of 0.01. This is a bad value and indicates that CBA is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.01, CBA is doing worse than 90.54% of the companies in the same industry.
A Quick Ratio of 0.01 indicates that CBA may have some problems paying its short term obligations.
CBA has a worse Quick ratio (0.01) than 90.54% of its industry peers.
Industry RankSector Rank
Current Ratio 0.01
Quick Ratio 0.01
CBA.CA Yearly Current Assets VS Current LiabilitesCBA.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M

0

3. Growth

3.1 Past

The earnings per share for CBA have decreased strongly by -26.19% in the last year.
The Revenue for CBA has decreased by -100.00% in the past year. This is quite bad
EPS 1Y (TTM)-26.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

CBA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CBA.CA Price Earnings VS Forward Price EarningsCBA.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CBA.CA Per share dataCBA.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.01 -0 0.01 0.02

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CBA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CHAMPION BEAR RESOURCES LTD

TSX-V:CBA (5/8/2025, 7:00:00 PM)

0.025

+0.01 (+25%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners11.25%
Ins Owner ChangeN/A
Market Cap1.88M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.25
P/tB 1.25
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS0.02
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.67%
ROE -22.38%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-6.1%
ROA(5y)-16.79%
ROE(3y)-17.09%
ROE(5y)-46.66%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1216.67%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.01
Quick Ratio 0.01
Altman-Z -7.83
F-Score1
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)5454.76%
Cap/Depr(5y)6039.65%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-26.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-8.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y52.39%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y48.86%
OCF growth 3YN/A
OCF growth 5YN/A